MTHFD2 is broadly required for cancer cell proliferation and viability as a metabolic enzyme and was overexpressed around the tumor regions with poor nutrient access in GBM patients, and the suppression of MTHFD2 could cause cancer cell death (Tanaka et al., 2021). Here, MTHFD2 is linked to cancer.